IL208151A0 - Long-term stable pharmaceutical preparation having the active ingredient glycerol trinitrate - Google Patents
Long-term stable pharmaceutical preparation having the active ingredient glycerol trinitrateInfo
- Publication number
- IL208151A0 IL208151A0 IL208151A IL20815110A IL208151A0 IL 208151 A0 IL208151 A0 IL 208151A0 IL 208151 A IL208151 A IL 208151A IL 20815110 A IL20815110 A IL 20815110A IL 208151 A0 IL208151 A0 IL 208151A0
- Authority
- IL
- Israel
- Prior art keywords
- long
- active ingredient
- pharmaceutical preparation
- term stable
- stable pharmaceutical
- Prior art date
Links
- SNIOPGDIGTZGOP-UHFFFAOYSA-N Nitroglycerin Chemical compound [O-][N+](=O)OCC(O[N+]([O-])=O)CO[N+]([O-])=O SNIOPGDIGTZGOP-UHFFFAOYSA-N 0.000 title 1
- 239000004480 active ingredient Substances 0.000 title 1
- 230000007774 longterm Effects 0.000 title 1
- 239000000825 pharmaceutical preparation Substances 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
- A61K9/006—Oral mucosa, e.g. mucoadhesive forms, sublingual droplets; Buccal patches or films; Buccal sprays
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/12—Carboxylic acids; Salts or anhydrides thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/08—Solutions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/14—Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/44—Oils, fats or waxes according to two or more groups of A61K47/02-A61K47/42; Natural or modified natural oils, fats or waxes, e.g. castor oil, polyethoxylated castor oil, montan wax, lignite, shellac, rosin, beeswax or lanolin
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Emergency Medicine (AREA)
- Nutrition Science (AREA)
- Physiology (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US4826408A | 2008-03-14 | 2008-03-14 | |
| PCT/EP2009/001772 WO2009112258A1 (en) | 2008-03-14 | 2009-03-12 | Long-term stable pharmaceutical preparation having the active ingredient glycerol trinitrate |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| IL208151A0 true IL208151A0 (en) | 2010-12-30 |
Family
ID=39670662
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IL208151A IL208151A0 (en) | 2008-03-14 | 2010-09-14 | Long-term stable pharmaceutical preparation having the active ingredient glycerol trinitrate |
Country Status (8)
| Country | Link |
|---|---|
| EP (1) | EP2254552B1 (en) |
| AU (1) | AU2009224968B2 (en) |
| BR (1) | BRPI0908577A2 (en) |
| CA (1) | CA2718345C (en) |
| DE (1) | DE202008007318U1 (en) |
| IL (1) | IL208151A0 (en) |
| RU (1) | RU2010142023A (en) |
| WO (1) | WO2009112258A1 (en) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20100184870A1 (en) | 2008-03-14 | 2010-07-22 | Rolf Groteluschen | Long-term stable pharmaceutical preparation containing the active ingredient glycerol trinitrate |
| EP2990032A1 (en) * | 2010-08-03 | 2016-03-02 | G. Pohl-Boskamp GmbH & Co. KG | Use of glyceryl trinitrate for treating traumatic edema |
| EP2678000B1 (en) | 2011-02-25 | 2018-03-07 | G. Pohl-Boskamp GmbH & Co. KG | Stabilized granules containing glyceryl trinitrate |
| ES2617494T3 (en) | 2012-05-31 | 2017-06-19 | G. Pohl-Boskamp Gmbh & Co. Kg | Induction of arteriogenesis with a nitric oxide donor such as nitroglycerin |
| US9248099B2 (en) | 2012-05-31 | 2016-02-02 | Desmoid Aktiengesellschaft | Use of stabilized granules containing glyceryl trinitrate for arteriogenesis |
| EP2878310B1 (en) | 2013-11-29 | 2017-01-11 | G. Pohl-Boskamp GmbH & Co. KG | Sprayable aqueous composition comprising glyceryl trinitrate |
Family Cites Families (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| BE632504A (en) | 1962-05-24 | |||
| JPS599539B2 (en) * | 1979-11-13 | 1984-03-03 | 日本化薬株式会社 | Nitroglycerin aqueous solution and its manufacturing method |
| CA1163195A (en) * | 1980-06-26 | 1984-03-06 | Alec D. Keith | Polymeric diffusion matrix containing a vasodilator |
| DE3246081A1 (en) | 1982-12-13 | 1984-06-14 | G. Pohl-Boskamp GmbH & Co Chemisch-pharmazeutische Fabrik, 2214 Hohenlockstedt | Nitroglycerin spray |
| DE4007705C1 (en) | 1990-03-10 | 1991-09-26 | G. Pohl-Boskamp Gmbh & Co. Chemisch-Pharmazeutische Fabrik, 2214 Hohenlockstedt, De | |
| US5370862A (en) * | 1990-06-13 | 1994-12-06 | Schwarz Pharma Ag | Pharmaceutical hydrophilic spray containing nitroglycerin for treating angina |
| DE4018919C2 (en) | 1990-06-13 | 1994-08-25 | Sanol Arznei Schwarz Gmbh | Nitroglycerin spray |
| DE4026072A1 (en) | 1990-08-17 | 1992-02-20 | Sanol Arznei Schwarz Gmbh | NITROGLYCER-CONTAINING, HYDROPHILIC, WAESSRING PUMPSPRAY |
| US5698589A (en) * | 1993-06-01 | 1997-12-16 | International Medical Innovations, Inc. | Water-based topical cream containing nitroglycerin and method of preparation and use thereof |
| US5869082A (en) | 1996-04-12 | 1999-02-09 | Flemington Pharmaceutical Corp. | Buccal, non-polar spray for nitroglycerin |
| WO1999038472A2 (en) * | 1998-01-28 | 1999-08-05 | Seatrace Pharmaceuticals Inc | Topical vasodilatory gel composition and methods of use and production |
| US20070059346A1 (en) * | 2003-07-01 | 2007-03-15 | Todd Maibach | Film comprising therapeutic agents |
-
2008
- 2008-05-30 DE DE202008007318U patent/DE202008007318U1/en not_active Expired - Lifetime
-
2009
- 2009-03-12 WO PCT/EP2009/001772 patent/WO2009112258A1/en not_active Ceased
- 2009-03-12 AU AU2009224968A patent/AU2009224968B2/en active Active
- 2009-03-12 RU RU2010142023/15A patent/RU2010142023A/en not_active Application Discontinuation
- 2009-03-12 CA CA2718345A patent/CA2718345C/en active Active
- 2009-03-12 BR BRPI0908577A patent/BRPI0908577A2/en not_active IP Right Cessation
- 2009-03-12 EP EP09720940.7A patent/EP2254552B1/en active Active
-
2010
- 2010-09-14 IL IL208151A patent/IL208151A0/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| DE202008007318U1 (en) | 2008-07-31 |
| EP2254552A1 (en) | 2010-12-01 |
| CA2718345C (en) | 2015-07-07 |
| BRPI0908577A2 (en) | 2017-05-16 |
| CA2718345A1 (en) | 2009-09-17 |
| WO2009112258A1 (en) | 2009-09-17 |
| RU2010142023A (en) | 2012-04-20 |
| AU2009224968A1 (en) | 2009-09-17 |
| EP2254552B1 (en) | 2016-08-24 |
| AU2009224968B2 (en) | 2014-01-16 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EP2522653A4 (en) | Biguanide derivative, a preparation method thereof and a pharmaceutical composition containing the biguanide derivative as an active ingredient | |
| ZA201101477B (en) | Co-crystals and pharmaceutical formulations comprising the same | |
| IL208858A (en) | Lipid-containing formulations, methods of selection and preparation of the same and uses thereof | |
| ZA201007805B (en) | Solid pharmaceutical formulations comprising bibw 2992 | |
| ZA201007870B (en) | Synergistic active ingredient combinations | |
| EP2039366A4 (en) | Composition containing peptide as the active ingredient | |
| PL2594248T3 (en) | Active ingredient combination and use thereof | |
| BRPI0915093A2 (en) | conjugates for the administration of biologically active compounds | |
| EP2112925A4 (en) | Solid pharmaceutical dosage formulations | |
| BRPI1009392A2 (en) | "pharmaceutical formulation, and use of a pharmaceutically effective amount of a pharmaceutical formulation." | |
| IL206808A (en) | Indolyl-pyridone derivatives, pharmaceutical compositions comprising the same and uses thereof | |
| EP2266626A4 (en) | Composition for external application comprising transcription factor decoy as active ingredient | |
| IL208370A0 (en) | Improved formulations for poorly permeable active pharmaceutical ingredients | |
| WO2010021607A3 (en) | Pharmaceutical formulation | |
| BRPI0807078A2 (en) | COMPOUND AND PHARMACEUTICAL FORMULATION | |
| WO2009135593A3 (en) | Solid pharmaceutical formulation with delayed release | |
| IL190698A0 (en) | Nanoparticulate active ingredient formulations | |
| EP2433631A4 (en) | Anti-inflammatory composition containing macrolactin a and a derivative thereof as active ingredients | |
| FR2938192B1 (en) | NEW ANTI-STRETCH ACTIVE INGREDIENTS AND COMPOSITIONS COMPRISING THE SAME | |
| HU0800591D0 (en) | Stable pharmaceutical combination | |
| WO2011135580A3 (en) | Pharmaceutical compositions of sirolimus | |
| IL208151A0 (en) | Long-term stable pharmaceutical preparation having the active ingredient glycerol trinitrate | |
| WO2011002422A3 (en) | Solubility enhancing pharmaceutical formulation | |
| EP2335697A4 (en) | Stable pharmaceutical formulation with limited discoloration | |
| IL208788A (en) | Solid pharmaceutical formulation |